Compared side by side
HGH vs sermorelin: how they differ
The short answer
HGH is recombinant growth hormone itself, an identical copy of the GH the pituitary makes; sermorelin is a copy of the first 29 amino acids of GHRH that prompts the pituitary to release its own GH, keeping the body’s feedback loops in play. HGH is FDA-approved for GH deficiency and several growth disorders, but not for aging or athletic use; sermorelin was FDA-approved until its maker discontinued it in 2008. Commonly reported: water retention, numb or tingling fingers and joint aches on HGH, and gentle, slow-building effects on sermorelin.
Side by side
| Compared | HGH | Sermorelin |
|---|---|---|
| Category | Growth hormone | Growth hormone |
| Also known as | GH, rHGH, Human Growth Hormone, Growth Hormone, Somatropin, hGH | GHRH 1-29, GRF 1-29 |
| What it is | Recombinant human growth hormone — an identical copy of the GH your pituitary makes. | A synthetic copy of the first 29 amino acids of your natural growth hormone releasing hormone: it prompts your pituitary to release its own GH, keeping the body's feedback loops in play. |
| How it works | Recombinant human growth hormone. Binds GH receptors to stimulate IGF-1 production, protein synthesis, and lipolysis. Promotes muscle growth, fat oxidation, and tissue repair. Structurally identical to pituitary GH, though injections don't reproduce its natural pulses. | Synthetic analogue of endogenous GHRH. Stimulates the pituitary to produce and secrete GH naturally. Considered a more physiological approach to GH optimization compared to exogenous GH. |
| Commonly reported | Water retention, numb or tingling fingers, joint aches, and better sleep and skin. Requires careful dosing and IGF-1 monitoring — more is not always better. | Deeper sleep and vivid dreams in the first weeks, with gentle, slow-building effects, milder than CJC/ipamorelin. It was FDA-approved as a diagnostic test (1990) and to treat GH deficiency in children (1997) until the maker discontinued it in 2008, not for safety reasons. |
| Studied range | Research range: 1–4 IU. Studied in research — not a recommendation. | Research range: 200–500 mcg, starting dose 200 mcg. Studied in research — not a recommendation. |
| How often | Daily SubQ injection. | Daily, before bed |
| Half-life | ~3-4 hours (SubQ) | ~11–12 min (US Geref label, after IV or SubQ) |
| Route | SubQ injection | SubQ injection |
| Typical run | Commonly reported starting dose 1-2 IU daily. Advanced users may run 3-4 IU split AM/PM. Cycles of 3-6+ months common. Monitor IGF-1 levels. Also run alongside peptide stacks; some advanced protocols add insulin, which isn't in this library. | 3–6 months common; considered a more physiological approach so longer cycles are used. |
| Evidence | Established: clinical trials or FDA-approved use exists | Established: clinical trials or FDA-approved use exists |
| Common side effects | Water retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions | Headache, flushing, dizziness, nausea, injection site reaction, water retention |
- Category
- HGHGrowth hormone
- SermorelinGrowth hormone
- Also known as
- HGHGH, rHGH, Human Growth Hormone, Growth Hormone, Somatropin, hGH
- SermorelinGHRH 1-29, GRF 1-29
- What it is
- HGHRecombinant human growth hormone — an identical copy of the GH your pituitary makes.
- SermorelinA synthetic copy of the first 29 amino acids of your natural growth hormone releasing hormone: it prompts your pituitary to release its own GH, keeping the body's feedback loops in play.
- How it works
- HGHRecombinant human growth hormone. Binds GH receptors to stimulate IGF-1 production, protein synthesis, and lipolysis. Promotes muscle growth, fat oxidation, and tissue repair. Structurally identical to pituitary GH, though injections don't reproduce its natural pulses.
- SermorelinSynthetic analogue of endogenous GHRH. Stimulates the pituitary to produce and secrete GH naturally. Considered a more physiological approach to GH optimization compared to exogenous GH.
- Commonly reported
- HGHWater retention, numb or tingling fingers, joint aches, and better sleep and skin. Requires careful dosing and IGF-1 monitoring — more is not always better.
- SermorelinDeeper sleep and vivid dreams in the first weeks, with gentle, slow-building effects, milder than CJC/ipamorelin. It was FDA-approved as a diagnostic test (1990) and to treat GH deficiency in children (1997) until the maker discontinued it in 2008, not for safety reasons.
- Studied range
- HGHResearch range: 1–4 IU. Studied in research — not a recommendation.
- SermorelinResearch range: 200–500 mcg, starting dose 200 mcg. Studied in research — not a recommendation.
- How often
- HGHDaily SubQ injection.
- SermorelinDaily, before bed
- Half-life
- HGH~3-4 hours (SubQ)
- Sermorelin~11–12 min (US Geref label, after IV or SubQ)
- Route
- HGHSubQ injection
- SermorelinSubQ injection
- Typical run
- HGHCommonly reported starting dose 1-2 IU daily. Advanced users may run 3-4 IU split AM/PM. Cycles of 3-6+ months common. Monitor IGF-1 levels. Also run alongside peptide stacks; some advanced protocols add insulin, which isn't in this library.
- Sermorelin3–6 months common; considered a more physiological approach so longer cycles are used.
- Evidence
- HGHEstablished: clinical trials or FDA-approved use exists
- SermorelinEstablished: clinical trials or FDA-approved use exists
- Common side effects
- HGHWater retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions
- SermorelinHeadache, flushing, dizziness, nausea, injection site reaction, water retention
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
HGH
Week-by-week cards for HGH are not in our library.
Sermorelin
- Day 1–14 Sleep is the first signal
- Day 14–42 Recovery and skin are responding
- Day 42–180 The long game is paying off
Questions people ask
How long do HGH and sermorelin last?
The half-life of HGH is ~3-4 hours (SubQ). The half-life of sermorelin is ~11–12 min (US Geref label, after IV or SubQ).
How often are HGH and sermorelin taken?
HGH: daily SubQ injection. Route: SubQ injection. Sermorelin: daily, before bed. Route: SubQ injection.
How are HGH and sermorelin dosed in research?
The research range for HGH is 1–4 IU. The research range for sermorelin is 200–500 mcg, with a 200 mcg starting dose. Studied in research — not a recommendation.
What are the common side effects of HGH and sermorelin?
For HGH, the library lists: water retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions. For sermorelin: headache, flushing, dizziness, nausea, injection site reaction, water retention.